Skip to content
Trial Eligibility
Menu

Reduction of Adverse Drug Events and Readmissions

NCT02738047

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pharmacogenomic Testing for Medication Management

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
25 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
ClinLogic LLC
Last updated on ClinicalTrials.gov
February 7, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • MD@Home · York, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.